Gilead Sciences
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 29% of the universe, above its 200-day average.
- Signal has read BUY for 6 days.
- Its last 4 Buy calls have averaged close to flat (-2%) three months out - no strong edge on this name specifically.
- Recent price momentum is +20.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 153.07
- Open
- 155.37
- Day range
- 154.02 - 157.48
- Avg price
- 155.92
- Volume
- 3.85M
- Turnover
- 599.93M
- Turnover ratei
- 0.31%
- Volume ratioi
- 0.61
- Amplitudei
- 2.26%
- 52-week rangei
- 111.27 - 160.51
Valuation
- P/Ei
- 22.99
- P/E (TTM)i
- -58.83
- P/Bi
- 16.34
- EPSi
- 6.78
- Book value / shi
- 9.54
- Net profit
- 8.41B
- Net assets
- 11.83B
Share structure
- Market cap
- 193.30B
- Float capi
- 192.89B
- Shares out
- 1.24B
- Float sharesi
- 1.24B
Dividend & listing
- Div yield (TTM)i
- 2.07%
- Dividend (TTM)
- 3.22
- Listing date
- 1992-01-24
2.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-237.49M net over the window
Short interest
- Shares short
- 21.83M
- % of floati
- 1.76%
- Days to coveri
- 3.36
- As of
- 2026-09-30
Frequently asked questions
What is the current stock price of Gilead Sciences (GILD)?
Gilead Sciences last traded at 155.90. The quote on this page refreshes every few seconds while US markets are open.
What is Gilead Sciences's market cap?
About 193.30B.
What is the P/E ratio of Gilead Sciences?
The trailing twelve-month P/E is -58.83, below its own 5-year average of 92.33 — toward the bottom of its historical range (0.16% percentile). See the Valuation tab for the full history.
Does Gilead Sciences pay a dividend?
Yes. The trailing dividend yield is 2.07%. The 2025 payout was up 2.6% from 2024. See the Dividends tab for the full payment history.
Is Gilead Sciences a buy according to analysts?
The consensus of 19 analysts is a Buy rating, with an average 12-month price target of 163.28, which implies 4.7% upside from the current price. This is not investment advice.
What is Gilead Sciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Gilead Sciences a B (Buy). Twelve-month momentum in the top 29% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-20 15:30:04 · For reference only, not investment advice and not tailored to your situation.
Gilead Sciences discussion 0 comments